Halozyme Therapeutics Inc (NASDAQ:HALO)

Thursday’s trading has closed, but HALO is being traded in the after-hours session. After-Hours quote »
15.28
Delayed Data
As of 4:00pm ET
 +0.11 / +0.73%
Today’s Change
6.88
Today|||52-Week Range
16.52
+58.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues13.6M56.1M42.3M54.8M
 
 
 
 
 
Cost of Goods Sold985.3K257.8K1.1M6.2M
 
 
 
 
 
Depreciation And Amortization1.5M1.1M1.1M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income11.1M54.7M40.2M47.3M
 
 
 
 
 
General Expenses63.3M74.6M93.8M127.8M
 
 
 
 
 
Research And Development50.6M57.6M69.0M95.4M
 
 
 
 
 
Total Operating Expenses65.8M75.9M96.0M135.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-52.1M-19.8M-53.6M-80.4M
 
 
 
 
 
Extraordinary Charge-2.1M0.000.000.00
 
 
Interest Expense On Debt0.000.000.003.3M
 
 
Other Expenses967.0K5.6K14.4K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.2M-19.8M-53.6M-83.5M
 
 
 
 
 
Net Income-53.2M-19.8M-53.6M-83.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS94.4M102.6M111.1M112.8M
 
 
 
 
 
Shares To Calculate EPS Diluted94.4M102.6M111.1M112.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.19-$0.48-$0.74
 
 
 
 
 
EPS Diluted-$0.56-$0.19-$0.48-$0.74
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account